Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis
Investigative Ophthalmology & Visual Science2023Vol. 64(10), pp. 30–30
Citations Over TimeTop 10% of 2023 papers
Zhiyan Tao, Wei Liu, Qin Chen, Libo Zhang, Kaiqin She, Guoqing Zhao, Licong Liang, Xuhong Chen, Yiliu Yang, Song Qin, Fang Lü
Abstract
Blocking Th2 signaling pathway alleviates the clinical symptoms and inflammation in AC.
Related Papers
- → Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751(2001)144 cited
- → Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis(2017)13 cited
- Enhancement of Conjunctival Inflammation by Corneal Epithelial Ablation in Experimental Allergic Conjunctivitis(2005)
- [Cellular and molecular bases of allergic diseases of the conjunctiva].(1999)
- Th9-induced conjunctival inflammation: A new animal model for allergic conjunctivitis(2015)